549 related articles for article (PubMed ID: 33181348)
1. Molecular characterization of pathogenicity locus (PaLoc) and tcdC genetic diversity among tcdA
Kodori M; Ghalavand Z; Yadegar A; Eslami G; Azimirad M; Krutova M; Abadi A; Zali MR
Anaerobe; 2020 Dec; 66():102294. PubMed ID: 33181348
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity locus determinants and toxinotyping of
Aliramezani A; Talebi M; Baghani A; Hajabdolbaghi M; Salehi M; Abdollahi A; Afhami S; Marjani M; Golbabaei F; Boroumand MA; Sarrafnejad A; Yaseri M; Ghourchian S; Douraghi M
New Microbes New Infect; 2018 Sep; 25():52-57. PubMed ID: 30094031
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity and phylogenetic analysis of the surface layer protein A gene (slpA) among Clostridioides difficile clinical isolates from Tehran, Iran.
Noori M; Ghalavand Z; Azimirad M; Yadegar A; Eslami G; Krutova M; Brajerova M; Goudarzi M; Zali MR
Anaerobe; 2021 Aug; 70():102403. PubMed ID: 34111549
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection in an Iranian hospital.
Jalali M; Khorvash F; Warriner K; Weese JS
BMC Res Notes; 2012 Mar; 5():159. PubMed ID: 22436392
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.
Spigaglia P; Mastrantonio P
J Clin Microbiol; 2002 Sep; 40(9):3470-5. PubMed ID: 12202595
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Clostridium difficile toxinotypes in infected patients at a tertiary care center in Lebanon.
Moukhaiber R; Araj GF; Kissoyan KA; Cheaito KA; Matar GM
J Infect Dev Ctries; 2015 Jul; 9(7):732-5. PubMed ID: 26230123
[TBL] [Abstract][Full Text] [Related]
8. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia.
Rupnik M; Kato N; Grabnar M; Kato H
J Clin Microbiol; 2003 Mar; 41(3):1118-25. PubMed ID: 12624039
[TBL] [Abstract][Full Text] [Related]
9.
Azimirad M; Krutova M; Yadegar A; Shahrokh S; Olfatifar M; Aghdaei HA; Fawley WN; Wilcox MH; Zali MR
Emerg Microbes Infect; 2020 Dec; 9(1):1432-1443. PubMed ID: 32520657
[No Abstract] [Full Text] [Related]
10. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
Doosti A; Mokhtari-Farsani A
Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
[TBL] [Abstract][Full Text] [Related]
11. Clostridioides difficile: Characterization of the circulating toxinotypes in an Argentinean public hospital.
Crivaro AN; Carasi P; Salto I; Hugo A; Soldavini Pelichotti PC; Bengoa A; Fragomeno M; Serradell MA; Minnaard J; Rolny I; Alul E; Arregui L; Fabra Martinez ME; Moreno Valero OJ; Facente A; Magariños F; Jewtuchowicz V; Pérez PF; Trejo FM
Rev Argent Microbiol; 2023; 55(1):73-82. PubMed ID: 35840437
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
Sirard S; Valiquette L; Fortier LC
J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985
[TBL] [Abstract][Full Text] [Related]
13. Predominance of Clostridioides difficile PCR ribotype 181 in northern Greece, 2016-2019.
Kachrimanidou M; Metallidis S; Tsachouridou O; Harmanus C; Lola V; Protonotariou E; Skoura L; Kuijper E
Anaerobe; 2022 Aug; 76():102601. PubMed ID: 35688364
[TBL] [Abstract][Full Text] [Related]
14. Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes.
Rupnik M; Brazier JS; Duerden BI; Grabnar M; Stubbs SLJ
Microbiology (Reading); 2001 Feb; 147(Pt 2):439-447. PubMed ID: 11158361
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the pathogenicity locus in Clostridium difficile strains.
Cohen SH; Tang YJ; Silva J
J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomics of
Janezic S; Dingle K; Alvin J; Accetto T; Didelot X; Crook DW; Lacy DB; Rupnik M
Microb Genom; 2020 Oct; 6(10):. PubMed ID: 33030421
[No Abstract] [Full Text] [Related]
17. The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.
Krutova M; Nyc O; Matejkova J; Kuijper EJ; Jalava J; Mentula S
J Microbiol Immunol Infect; 2018 Jun; 51(3):344-351. PubMed ID: 28583353
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Clostridioides difficile isolates recovered from hospitalized patients and the hospitals environment and air: A multicenter study.
Aliramezani A; Talebi M; Golbabaei F; Baghani A; Marjani M; Afhami S; Hajabdolbaghi M; Boroumand MA; Kuijper EJ; Douraghi M
Anaerobe; 2019 Oct; 59():154-158. PubMed ID: 31247292
[TBL] [Abstract][Full Text] [Related]
19. Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
Dingle KE; Griffiths D; Didelot X; Evans J; Vaughan A; Kachrimanidou M; Stoesser N; Jolley KA; Golubchik T; Harding RM; Peto TE; Fawley W; Walker AS; Wilcox M; Crook DW
PLoS One; 2011; 6(5):e19993. PubMed ID: 21625511
[TBL] [Abstract][Full Text] [Related]
20. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
